CH625788A5 - - Google Patents

Download PDF

Info

Publication number
CH625788A5
CH625788A5 CH742380A CH742380A CH625788A5 CH 625788 A5 CH625788 A5 CH 625788A5 CH 742380 A CH742380 A CH 742380A CH 742380 A CH742380 A CH 742380A CH 625788 A5 CH625788 A5 CH 625788A5
Authority
CH
Switzerland
Prior art keywords
piperidine
formula
phenoxymethyl
benzoyl
compounds
Prior art date
Application number
CH742380A
Other languages
German (de)
English (en)
Inventor
Walter-Gunar Dr Rer Nat Friebe
Max Dr Rer Nat Thiel
Kurt Dr Stach
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CH625788A5 publication Critical patent/CH625788A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH742380A 1975-11-07 1980-10-03 CH625788A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH625788A5 true CH625788A5 (ja) 1981-10-15

Family

ID=5961166

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1385576A CH624102A5 (ja) 1975-11-07 1976-11-03
CH742480A CH627166A5 (ja) 1975-11-07 1980-10-03
CH742380A CH625788A5 (ja) 1975-11-07 1980-10-03

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH1385576A CH624102A5 (ja) 1975-11-07 1976-11-03
CH742480A CH627166A5 (ja) 1975-11-07 1980-10-03

Country Status (20)

Country Link
US (1) US4243807A (ja)
JP (1) JPS6055509B2 (ja)
AT (1) AT352726B (ja)
BE (1) BE847973A (ja)
CA (1) CA1077942A (ja)
CH (3) CH624102A5 (ja)
DD (1) DD126942A5 (ja)
DE (1) DE2549999A1 (ja)
DK (1) DK494876A (ja)
FI (1) FI763148A (ja)
FR (1) FR2330678A1 (ja)
GB (1) GB1502050A (ja)
HU (1) HU171237B (ja)
IE (1) IE43866B1 (ja)
IT (1) IT1063618B (ja)
LU (1) LU76141A1 (ja)
NL (1) NL7612286A (ja)
SE (1) SE7612234L (ja)
SU (3) SU633473A3 (ja)
ZA (1) ZA766381B (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
ATE188379T1 (de) * 1992-10-14 2000-01-15 Merck & Co Inc Fibrinogenrezeptor-antagonisten
AU675689B2 (en) * 1992-12-01 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
EP0881215B1 (en) * 1995-09-28 2001-09-05 Kaken Pharmaceutical Co., Ltd. Process for the preparation of 4-methylenepiperidines
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
US7888386B2 (en) * 2008-07-24 2011-02-15 Theravance, Inc. 3-(phenoxyphenylmethyl)pyrrolidine compounds
RU2503662C2 (ru) 2008-11-14 2014-01-10 Тереванс, Инк. Кристаллическая форма 4-[2-(2-фторфеноксиметил)фенил]пиперидинового соединения
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
RU2535669C2 (ru) * 2009-07-13 2014-12-20 Тереванс, Инк. 3-феноксиметилпирролидиновые соединения
JP5714580B2 (ja) * 2009-07-21 2015-05-07 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー 3−フェノキシメチルピロリジン化合物
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
ES2543064T3 (es) * 2010-03-22 2015-08-14 Theravance Biopharma R&D Ip, Llc Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina
EP2627630B1 (en) 2010-10-11 2014-12-31 Theravance Biopharma R&D IP, LLC Serotonin reuptake inhibitors
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2549999C2 (ja) 1989-01-26
GB1502050A (en) 1978-02-22
JPS5259163A (en) 1977-05-16
DD126942A5 (ja) 1977-08-24
ZA766381B (en) 1977-10-26
LU76141A1 (ja) 1977-05-18
NL7612286A (nl) 1977-05-10
FR2330678B1 (ja) 1980-11-07
SE7612234L (sv) 1977-05-07
CH627166A5 (ja) 1981-12-31
DE2549999A1 (de) 1977-05-12
BE847973A (fr) 1977-05-04
HU171237B (hu) 1977-12-28
IE43866B1 (en) 1981-06-17
SU867298A3 (ru) 1981-09-23
CA1077942A (en) 1980-05-20
AT352726B (de) 1979-10-10
FR2330678A1 (fr) 1977-06-03
DK494876A (da) 1977-05-08
IT1063618B (it) 1985-02-11
IE43866L (en) 1977-05-07
US4243807A (en) 1981-01-06
CH624102A5 (ja) 1981-07-15
FI763148A (ja) 1977-05-08
SU633473A3 (ru) 1978-11-15
ATA823776A (de) 1979-03-15
SU662009A3 (ru) 1979-05-05
JPS6055509B2 (ja) 1985-12-05

Similar Documents

Publication Publication Date Title
CH625788A5 (ja)
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
EP0007019A1 (de) Neue 5-Phenylpyrazol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
CH597199A5 (en) 3-Phenyl pyridaz-6-ones prodn.
DE1595920A1 (de) 4-(omega-Piperazinoalkyl)-pyrazole,ihre Salze und Verfahren zu ihrer Herstellung
AT360020B (de) Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
DE2642608C2 (de) Verfahren zur Herstellung eines 4-Hydroxymethyl-2-pyrrolidinons
AT360019B (de) Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
DE1908496A1 (de) Neue Thiophenderivate und Verfahren zu ihrer Herstellung
DE3816634A1 (de) Cyclobuten-3,4-dion-zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE955595C (de) Verfahren zur Herstellung von spasmolytisch wirksamen basischen AEthern endocyclisch substituierter Carbinole und ihren Salzen
DE2604248C2 (de) Verfahren zur Herstellung von Thienopyridinderivaten
AT344687B (de) Verfahren zur herstellung von neuen aldehydolactonen
CH620414A5 (ja)
DE3003323A1 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
AT256839B (de) Verfahren zur Herstellung von neuen substituierten 1-Cyclopropylmethy-piperidinen
DE1470215A1 (de) Neue heterocyclische Verbindungen und Verfahren zu deren Herstellung
DE2338409A1 (de) Neues verfahren zur herstellung von 2-acylamino-benzylaminen
DE1246742B (de) Verfahren zur Herstellung von neuen Phenothiazinen
AT252233B (de) Verfahren zur Herstellung von neuen basisch substituierten Pseudoindolen
AT336004B (de) Verfahren zur herstellung neuer 3-(4-biphenylyl)-buttersauren, ihrer ester, amide und salze
AT226235B (de) Verfahren zur Herstellung von neuen Thioxanthen-Derivaten
AT274802B (de) Verfahren zur Herstellung von Indolderivaten
AT367394B (de) Verfahren zur herstellung neuer indanderivate
DE2166997B2 (de) Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen

Legal Events

Date Code Title Description
PL Patent ceased